FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3112909621> ?p ?o ?g. }

• W3112909621 abstract "The aim of this study was to develop a widely accepted prognostic nomogram and establish a risk-adapted PMRT strategy based on locoregional recurrence for pT1-2N1M0 breast cancer.A total of 3,033 patients with pT1-2N1M0 breast cancer treated at 6 participating institutions between 2000 and 2016 were retrospectively reviewed. A nomogram was developed to predicted locoregional recurrence-free survival (LRFS). A propensity score-matched (PSM) analyses was performed in risk-adapted model.With the median follow-up of 65.0 months, the 5-year overall survival (OS), disease free survival (DFS) and LRFS were 93.0, 84.8, and 93.6%, respectively. There was no significant difference between patients who received PMRT or not for the entire group. A nomogram was developed and validated to estimate the probability of 5-year LRFS based on five independent factors including age, primary tumor site, positive lymph nodes number, pathological T stage, and molecular subtype that were selected by a multivariate analysis of patients who did not receive PMRT in the primary cohort. According to the total nomogram risk scores, the entire patients were classified into low- (40.0%), moderate- (42.4%), and high-risk group (17.6%). The 5-year outcomes were significantly different among these three groups (P<0.001). In low-risk group, patients who received PMRT or not both achieved a favorable OS, DFS, and LRFS. In moderate-risk group, no differences in OS, DFS, and LRFS were observed between PMRT and no PMRT patients. In high-risk group, compared with no PMRT, PMRT resulted in significantly different OS (86.8 vs 83.9%, P = 0.050), DFS (77.2 vs 70.9%, P = 0.049), and LRFS (90.8 vs. 81.6%, P = 0.003). After PSM adjustment, there were no significant differences in OS, DFS, and LRFS in low-risk and moderate-risk groups. However, in the high-risk group, PMRT still resulted in significantly better OS, DFS and improved LRFS.The proposed nomogram provides an individualized risk estimate of LRFS in patients with pT1-2N1M0 breast cancer. Risk-adapted PMRT for high-risk patients is a viable effective strategy." @default.
• W3112909621 created "2020-12-21" @default.
• W3112909621 creator A5001624029 @default.
• W3112909621 creator A5003662438 @default.
• W3112909621 creator A5007222967 @default.
• W3112909621 creator A5010796711 @default.
• W3112909621 creator A5012988764 @default.
• W3112909621 creator A5035001498 @default.
• W3112909621 creator A5037582901 @default.
• W3112909621 creator A5037773587 @default.
• W3112909621 creator A5053922118 @default.
• W3112909621 creator A5077245587 @default.
• W3112909621 creator A5081749078 @default.
• W3112909621 date "2020-12-11" @default.
• W3112909621 modified "2023-10-01" @default.
• W3112909621 title "Risk-Adapted Postmastectomy Radiotherapy Decision Based on Prognostic Nomogram for pT1-2N1M0 Breast Cancer: A Multicenter Study" @default.
• W3112909621 cites W1948261638 @default.
• W3112909621 cites W1968438702 @default.
• W3112909621 cites W1977748826 @default.
• W3112909621 cites W2011547014 @default.
• W3112909621 cites W2013305796 @default.
• W3112909621 cites W2046826982 @default.
• W3112909621 cites W2054028560 @default.
• W3112909621 cites W2060051234 @default.
• W3112909621 cites W2060250348 @default.
• W3112909621 cites W2062298610 @default.
• W3112909621 cites W2071727045 @default.
• W3112909621 cites W2073762437 @default.
• W3112909621 cites W2092625465 @default.
• W3112909621 cites W2092950740 @default.
• W3112909621 cites W2111549782 @default.
• W3112909621 cites W2119975486 @default.
• W3112909621 cites W2122761438 @default.
• W3112909621 cites W2123963334 @default.
• W3112909621 cites W2129825983 @default.
• W3112909621 cites W2130840692 @default.
• W3112909621 cites W2136112002 @default.
• W3112909621 cites W2138652241 @default.
• W3112909621 cites W2140978771 @default.
• W3112909621 cites W2147833901 @default.
• W3112909621 cites W2152911173 @default.
• W3112909621 cites W2158615473 @default.
• W3112909621 cites W2162852953 @default.
• W3112909621 cites W2163910197 @default.
• W3112909621 cites W2168517539 @default.
• W3112909621 cites W2171015116 @default.
• W3112909621 cites W2285456521 @default.
• W3112909621 cites W2332829713 @default.
• W3112909621 cites W2413870184 @default.
• W3112909621 cites W2800860148 @default.
• W3112909621 cites W2807500538 @default.
• W3112909621 cites W2912993657 @default.
• W3112909621 cites W3017713894 @default.
• W3112909621 cites W3094571296 @default.
• W3112909621 cites W4300071116 @default.
• W3112909621 doi "https://doi.org/10.3389/fonc.2020.588859" @default.
• W3112909621 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7761288" @default.
• W3112909621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33363018" @default.
• W3112909621 hasPublicationYear "2020" @default.
• W3112909621 type Work @default.
• W3112909621 sameAs 3112909621 @default.
• W3112909621 citedByCount "3" @default.
• W3112909621 countsByYear W31129096212021 @default.
• W3112909621 countsByYear W31129096212023 @default.
• W3112909621 crossrefType "journal-article" @default.
• W3112909621 hasAuthorship W3112909621A5001624029 @default.
• W3112909621 hasAuthorship W3112909621A5003662438 @default.
• W3112909621 hasAuthorship W3112909621A5007222967 @default.
• W3112909621 hasAuthorship W3112909621A5010796711 @default.
• W3112909621 hasAuthorship W3112909621A5012988764 @default.
• W3112909621 hasAuthorship W3112909621A5035001498 @default.
• W3112909621 hasAuthorship W3112909621A5037582901 @default.
• W3112909621 hasAuthorship W3112909621A5037773587 @default.
• W3112909621 hasAuthorship W3112909621A5053922118 @default.
• W3112909621 hasAuthorship W3112909621A5077245587 @default.
• W3112909621 hasAuthorship W3112909621A5081749078 @default.
• W3112909621 hasBestOaLocation W31129096211 @default.
• W3112909621 hasConcept C121608353 @default.
• W3112909621 hasConcept C126322002 @default.
• W3112909621 hasConcept C143998085 @default.
• W3112909621 hasConcept C146357865 @default.
• W3112909621 hasConcept C151730666 @default.
• W3112909621 hasConcept C29456083 @default.
• W3112909621 hasConcept C34626388 @default.
• W3112909621 hasConcept C38180746 @default.
• W3112909621 hasConcept C509974204 @default.
• W3112909621 hasConcept C530470458 @default.
• W3112909621 hasConcept C71924100 @default.
• W3112909621 hasConcept C86803240 @default.
• W3112909621 hasConceptScore W3112909621C121608353 @default.
• W3112909621 hasConceptScore W3112909621C126322002 @default.
• W3112909621 hasConceptScore W3112909621C143998085 @default.
• W3112909621 hasConceptScore W3112909621C146357865 @default.
• W3112909621 hasConceptScore W3112909621C151730666 @default.
• W3112909621 hasConceptScore W3112909621C29456083 @default.
• W3112909621 hasConceptScore W3112909621C34626388 @default.
• W3112909621 hasConceptScore W3112909621C38180746 @default.
• W3112909621 hasConceptScore W3112909621C509974204 @default.
• W3112909621 hasConceptScore W3112909621C530470458 @default.
• W3112909621 hasConceptScore W3112909621C71924100 @default.

• next